1.1 Articolo in rivista

1.1 Articolo in rivista: [31121] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 9.481 a 9.500 di 31.121

An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 1997; 77: 605-606

1997-01-01 Margaglione, M; Grandone, E; Cappucci, G; Colaizzo, D; Giuliani, N; Vecchione, G; D’Addedda, M; Di Minno, G

In vivo platelet activation in homozygous cystathionine beta-synthase deficiency: a probucol-sensitive phenomenon. Trans Assoc Am Physicians. 1992; 105:149-56

1992-01-01 Di Minno, G; Margaglione, M; Cirillo, F; Grandone, E; Davi, G; Ciabattoni, G; Catalano, I; Strisciuglio, P; Andria, G; Coppola, A; Et, Al

Factor V Leiden is associated with repeated and recurrent unexplained fetal losses

1997-01-01 Grandone, E; Margaglione, M; Colaizzo, D; D\'Anedda, M; Cappucci, G; Vecchione, G; Sciannamé, N; Pavone, G; DI MINNO, G

.A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood. 105(2):645-9; 2005

2005-01-01 D'Andrea, G; D'Ambrosio, Rl; Di Perna, P; Chetta, M; Santacroce, R; Brancaccio, V; Grandone, E; Margaglione, M

Identification of FVIII gene mutations in patients with hemophilia A using new combinatorial sequencing by hybridization. Indian J Hum Genet. 2008 May;14(2):55-64

2008-01-01 Chetta, M; Drmanac, A; Santacroce, R; Grandone, E; Surrey, S; Fortina, P; Margaglione, M

. Plasminogen activator inhibitor-1 (PAI-1) plasma levels in a general population without clinical evidence of atherosclerosis. Relation to environmental and genetic determinants. Arterioscler. Thromb. Vasc. Biol. 18:562-567; 1998

1998-01-01 Margaglione, M; Cappucci, G; D’Addedda, M; Colaizzo, D; Giuliani, N; Vecchione, G; Mascolo, G; Grandone, E; Di Minno, G

A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis

2007-01-01 Colaizzo, D; Amitrano, L; Tiscia, Gl; Grandone, E; Guardascione, Ma; Margaglione, ; M,

. Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica 2004; 89(12):1510-6.

2004-01-01 D'Ambrosio, Rl; D'Andrea, G; Cappucci, F; Chetta, M; Di Perna, P; Brancaccio, V; Grandone, E; Margaglione, M

Presence of Factor V Leiden and MTHFR mutation in a patient with complicated pregnancies. Thromb Haemost. 1997; 77: 1036-1037

1997-01-01 Grandone, E; Margaglione, M; Colaizzo, D; Pavone, G; Di Minno, G

Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost. 2000; 84(5):775-8

2000-01-01 Margaglione, M; Colaizzo, D; D'Andrea, G; Brancaccio, V; Ciampa, A; Grandone, E; Di Minno, G

Anticoagulant prophylaxis in women affected by thrombophilia and previous obstetric complications]

2008-01-01 Grandone, E; Colaizzo, D; Vergura, P; Tiscia, G; Chinni, E; Tomaiuolo, M; Margaglione, M

Protein Z levels and unexplained fetal losses. Fertil Steril.;82(4):982-3; 2004

2004-01-01 Grandone, E; Colaizzo, D; Cappucci, F; Cocomazzi, N; Margaglione, M

Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost. 2006; 4(11):2417-22.

2006-01-01 Santacroce, R; Sarno, M; Cappucci, F; Sessa, F; Colaizzo, D; Brancaccio, V; Grandone, E; Margaglione, M

Mechanisms of fibrinolysis and clinical use of thrombolytic agents. Prog Drug Res. 1992; 39:197-217.

1992-01-01 Margaglione, M; Grandone, E; Di Minno, G

Fetal sex identification in maternal plasma by means of short tandem repeats on chromosome x

2008-01-01 Vecchione, G; Tomaiuolo, M; Sarno, M; Colaizzo, D; Petraroli, R; Matteo, M; Greco, ; P, ; Grandone, E; Margaglione, M

A rapid method for the quantification of the enantiomers of Warfarin, Phenprocoumon and Acenocoumarol by two-dimensional-enantioselective liquid chromatography/electrospray tandem mass spectrometry

2007-01-01 Vecchione, G; Casetta, B; Tomaiuolo, M; Grandone, E; Margaglione, M

PLASMIC score: Not intended to replace but rather to prompt the ADAMTS13 testing.

2020-01-01 Tiscia, Gl; Grandone, E

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and Probucol-sensitive mechanism. J. Clin. Invest. 1993; 92:1400-1406

1993-01-01 Di Minno, G; Davì, G; Margaglione, M; Cirillo, F; Grandone, E; Ciabattoni, G; Catalano, I; Strisciuglio, P; Andria, G; Patrono, C; Mancini, M

Corporate governance model, stakeholder engagement and social issues. Evidence from European oil and gas industry.

2021-01-01 Doni, F.; Corvino, A.; Bianchi Martini, S.

. Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib gene in a patient with a severe bleeding tendency. Thromb Haemost 1999, 81(4): 486-92

1999-01-01 Margaglione, M; D’Andrea, G; Grandone, E; Brancaccio, V; Amoriello, A; Di Minno, G

Titolo	Data di pubblicazione	Autore(i)
An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 1997; 77: 605-606	1-gen-1997	Margaglione, M; Grandone, E; Cappucci, G; Colaizzo, D; Giuliani, N; Vecchione, G; D’Addedda, M; Di Minno, G
In vivo platelet activation in homozygous cystathionine beta-synthase deficiency: a probucol-sensitive phenomenon. Trans Assoc Am Physicians. 1992; 105:149-56	1-gen-1992	Di Minno, G; Margaglione, M; Cirillo, F; Grandone, E; Davi, G; Ciabattoni, G; Catalano, I; Strisciuglio, P; Andria, G; Coppola, A; Et, Al
Factor V Leiden is associated with repeated and recurrent unexplained fetal losses	1-gen-1997	Grandone, E; Margaglione, M; Colaizzo, D; D\'Anedda, M; Cappucci, G; Vecchione, G; Sciannamé, N; Pavone, G; DI MINNO, G
.A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood. 105(2):645-9; 2005	1-gen-2005	D'Andrea, G; D'Ambrosio, Rl; Di Perna, P; Chetta, M; Santacroce, R; Brancaccio, V; Grandone, E; Margaglione, M
Identification of FVIII gene mutations in patients with hemophilia A using new combinatorial sequencing by hybridization. Indian J Hum Genet. 2008 May;14(2):55-64	1-gen-2008	Chetta, M; Drmanac, A; Santacroce, R; Grandone, E; Surrey, S; Fortina, P; Margaglione, M
. Plasminogen activator inhibitor-1 (PAI-1) plasma levels in a general population without clinical evidence of atherosclerosis. Relation to environmental and genetic determinants. Arterioscler. Thromb. Vasc. Biol. 18:562-567; 1998	1-gen-1998	Margaglione, M; Cappucci, G; D’Addedda, M; Colaizzo, D; Giuliani, N; Vecchione, G; Mascolo, G; Grandone, E; Di Minno, G
A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis	1-gen-2007	Colaizzo, D; Amitrano, L; Tiscia, Gl; Grandone, E; Guardascione, Ma; Margaglione, ; M,
. Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica 2004; 89(12):1510-6.	1-gen-2004	D'Ambrosio, Rl; D'Andrea, G; Cappucci, F; Chetta, M; Di Perna, P; Brancaccio, V; Grandone, E; Margaglione, M
Presence of Factor V Leiden and MTHFR mutation in a patient with complicated pregnancies. Thromb Haemost. 1997; 77: 1036-1037	1-gen-1997	Grandone, E; Margaglione, M; Colaizzo, D; Pavone, G; Di Minno, G
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost. 2000; 84(5):775-8	1-gen-2000	Margaglione, M; Colaizzo, D; D'Andrea, G; Brancaccio, V; Ciampa, A; Grandone, E; Di Minno, G
Anticoagulant prophylaxis in women affected by thrombophilia and previous obstetric complications]	1-gen-2008	Grandone, E; Colaizzo, D; Vergura, P; Tiscia, G; Chinni, E; Tomaiuolo, M; Margaglione, M
Protein Z levels and unexplained fetal losses. Fertil Steril.;82(4):982-3; 2004	1-gen-2004	Grandone, E; Colaizzo, D; Cappucci, F; Cocomazzi, N; Margaglione, M
Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost. 2006; 4(11):2417-22.	1-gen-2006	Santacroce, R; Sarno, M; Cappucci, F; Sessa, F; Colaizzo, D; Brancaccio, V; Grandone, E; Margaglione, M
Mechanisms of fibrinolysis and clinical use of thrombolytic agents. Prog Drug Res. 1992; 39:197-217.	1-gen-1992	Margaglione, M; Grandone, E; Di Minno, G
Fetal sex identification in maternal plasma by means of short tandem repeats on chromosome x	1-gen-2008	Vecchione, G; Tomaiuolo, M; Sarno, M; Colaizzo, D; Petraroli, R; Matteo, M; Greco, ; P, ; Grandone, E; Margaglione, M
A rapid method for the quantification of the enantiomers of Warfarin, Phenprocoumon and Acenocoumarol by two-dimensional-enantioselective liquid chromatography/electrospray tandem mass spectrometry	1-gen-2007	Vecchione, G; Casetta, B; Tomaiuolo, M; Grandone, E; Margaglione, M
PLASMIC score: Not intended to replace but rather to prompt the ADAMTS13 testing.	1-gen-2020	Tiscia, Gl; Grandone, E
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and Probucol-sensitive mechanism. J. Clin. Invest. 1993; 92:1400-1406	1-gen-1993	Di Minno, G; Davì, G; Margaglione, M; Cirillo, F; Grandone, E; Ciabattoni, G; Catalano, I; Strisciuglio, P; Andria, G; Patrono, C; Mancini, M
Corporate governance model, stakeholder engagement and social issues. Evidence from European oil and gas industry.	1-gen-2021	Doni, F.; Corvino, A.; Bianchi Martini, S.
. Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib gene in a patient with a severe bleeding tendency. Thromb Haemost 1999, 81(4): 486-92	1-gen-1999	Margaglione, M; D’Andrea, G; Grandone, E; Brancaccio, V; Amoriello, A; Di Minno, G

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 9.481 a 9.500 di 31.121

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext30651
open363
restricted77
reserved29
partially open1